Vesicle Transport through Interaction with T-SNAREs Homolog 1B (VTI1B) (C-Term) Peptide
VTI1B
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all VTI1B products
- VTI1B (Vesicle Transport through Interaction with T-SNAREs Homolog 1B (VTI1B))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- IERSHRIATE TDQIGSEIIE ELGEQRDQLE RTKSRLVNTS ENLSKSRKIL
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-VTI1B Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- VTI1B (Vesicle Transport through Interaction with T-SNAREs Homolog 1B (VTI1B))
- Background
-
V-SNARE that mediates vesicle transport pathways through interactions with t-SNAREs on the target membrane. These interactions are proposed to mediate aspects of the specificity of vesicle trafficking and to promote fusion of the lipid bilayers. It may be concerned with increased secretion of cytokines associated with cellular senescence.
Alias Symbols: VTI1, VTI1-LIKE, VTI1L, VTI2, v-SNARE, vti1-rp1
Protein Size: 232 - Molecular Weight
- 26 kDa
- Gene ID
- 10490
- NCBI Accession
- NM_006370, NP_006361
- UniProt
- Q9UEU0
-
You are here:
